Stocktoria
Welsis Corp. WLSS
OTC · stock · Services-Health Services · website · IPO 2023-06-07
Welsis Corp. financials (annual, from 10-K)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $2,000 | $30,900 | $0 | $0 |
| Gross profit | $0 | $2,000 | $15,900 | — | — |
| Operating income | -$50,573 | -$57,898 | -$37,072 | -$42,785 | -$56,899 |
| Interest expense | $10,117 | $6,452 | $3,996 | — | — |
| Income tax | — | — | $0 | $0 | $0 |
| Net income | -$60,690 | -$24,683 | -$41,068 | -$42,785 | -$56,899 |
| EPS (diluted) | $-0.02 | $-0.01 | $-0.01 | $0.00 | $0.00 |
| Operating cash flow | -$49,947 | -$29,979 | -$21,872 | -$38,789 | -$56,566 |
| Cash & equivalents | — | — | — | — | $0 |
| Total assets | $2,169 | $0 | $33,167 | $50,036 | $39,334 |
| Total liabilities | $152,500 | $89,641 | $151,140 | $126,941 | $96,033 |
| Shareholders' equity | -$150,331 | -$89,641 | -$117,973 | -$76,905 | -$56,699 |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | -100.0% | -93.5% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001887912 · US · as of 2025-09-30. facts plus Stocktoria's own computed scores — not investment advice.